Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 May 23;19(5):e0299247. doi: 10.1371/journal.pone.0299247

Distribution of antibiotic resistance genes and antibiotic residues in drinking water production facilities: Links to bacterial community

Karabo Tsholo 1,*, Lesego Gertrude Molale-Tom 1, Suranie Horn 1,2, Cornelius Carlos Bezuidenhout 1
Editor: António Machado3
PMCID: PMC11115235  PMID: 38781192

Abstract

There is a rapid spread of antibiotic resistance in the environment. However, the impact of antibiotic resistance in drinking water is relatively underexplored. Thus, this study aimed to quantify antibiotic resistance genes (ARGs) and antibiotic residues in two drinking water production facilities (NW-E and NW-C) in North West Province, South Africa and link these parameters to bacterial communities. Physicochemical and ARG levels were determined using standard procedures. Residues (antibiotics and fluconazole) and ARGs were quantified using ultra-high performance liquid chromatography (UHPLC) chemical analysis and real-time PCR, respectively. Bacterial community compositions were determined by high-throughput 16S rRNA sequencing. Data were analysed using redundancy analysis and pairwise correlation. Although some physicochemical levels were higher in treated than in raw water, drinking water in NW-E and NW-C was safe for human consumption using the South African Water Quality Guideline (SAWQG). ARGs were detected in raw and treated water. In NW-E, the concentrations of ARGs (sul1, intl1, EBC, FOX, ACC and DHA) were higher in treated water than in raw water. Regarding antimicrobial agents, antibiotic and fluconazole concentrations were higher in raw than in treated water. However, in NW-C, trimethoprim concentrations were higher in raw than in treated water. Redundancy analysis showed that bacterial communities were not significantly correlated (Monte Carlo simulations, p-value >0.05) with environmental factors. However, pairwise correlation showed significant differences (p-value <0.05) for Armatimonas, CL500-29 marine group, Clade III, Dickeya and Zymomonas genera with environmental factors. The presence of ARGs and antibiotic residues in the current study indicated that antibiotic resistance is not only a clinical phenomenon but also in environmental settings, particularly in drinking water niches. Consumption of NW-E and NW-C treated water may facilitate the spread of antibiotic resistance among consumers. Thus, regulating and monitoring ARGs and antibiotic residues in drinking water production facilities should be regarded as paramount.

Introduction

Antibiotics have revolutionized medicine and improved the prevention and treatment of infectious bacteria, thus reducing the mortality burden on humans and animals. Hence, antibiotic use has become common worldwide, leading to the accumulation and spread of antibiotic resistance [1, 2]. In addition, the lack of development of new generations of antibiotics has threatened the effective treatment of infectious bacteria with common antibiotics [3]. Unfortunately, antibiotic resistance complicates treatment requiring extended hospitalization and high-cost drugs to treat common bacterial infections [4, 5].

Antibiotic resistance may be high in South Africa since the country has a heightened usage of antibiotics comparable and sometimes higher than those in BRICS (Brazil, Russia, India, Canada and South Africa) nations, the United States and the United Kingdom [6]. The aforementioned report further revealed that in 2015, more than 60% of the antibiotics procured in South Africa for human health were used as growth promoters. In addition to this high use of antibiotics, the antifungal, fluconazole, is prescribed to people living with HIV/AIDS (PLWH) and since South Africa has 13.7% PLWH, fluconazole is highly used [7, 8] and was included in the analysis. The extensive usage of antimicrobials has led to the spread of antibiotic residues in the aquatic environment since human and animal bodies cannot fully metabolize antibiotics [9].

Aquatic environments are important vectors of antibiotic resistance, which provide favourable conditions for bacterial growth and spread antibiotic resistance genes (ARGs) via horizontal gene transfer to other species [10, 11]. However, in South Africa, antibiotic resistance is not monitored and regulated in aquatic environments despite being reported in drinking water [12, 13]. Furthermore, studies addressing antibiotic resistance in drinking water focus on detecting ARGs and not so much on quantifying ARGs and antibiotic residues. Antibiotic and ARG concentrations are essential for developing quantitative risk assessments on consumers [14, 15].

Moreover, most studies resorted to culture-dependent techniques due to the complexities of sampling drinking water for culture-independent techniques [16]. Culture-dependent techniques do not account for viable but non-culturable bacteria that may be opportunistic bacteria harbouring ARGs [17]. High-throughput 16S rRNA sequencing could be used to overcome this limitation [18, 19]. Thus, this study aimed to quantify antibiotic resistance genes and antimicrobial residues in two drinking water production facilities (NW-E and NW-C) in North West Province, South Africa and to understand how bacterial community composition is linked to ARGs, antimicrobial residues and physicochemical parameters.

Materials and methods

Study area

Raw and treated water samples were collected in two DWPFs (NW-E and NW-C) in North West, South Africa. The NW-E DWPF has a total design capacity of 736 Mℓ/day and relies on two raw water sources to produce drinking water [20]. This plant services a population of 162 762 [21]. Treatment processes involved in NW-E DWPF include coagulation-flocculation, sedimentation, sand filtration, activated carbon and chlorination. The NW-C DWPF, with a total design capacity of 14 Mℓ/day, use physical separation, sand filtration and chlorination to treat water for the population of 28 720 [20, 22]. The municipality permitted the study of these DWPFs on a condition of anonymity.

Sampling

Grab samples were collected in sterile 1 L bottles (Duran Schott, Germany) to isolate environmental DNA (eDNA). Acid-washed (free from chemical contaminants) 1 L bottles (Duran Schott, Germany) were used for the collection of samples for chemical analysis. However, up to 5 L of samples used for isolation eDNA were collected due to the complexities of sampling treated water [16]. Sampling was from October 2020 until March 2022. Samples were collected and transported in ice to the North-West University laboratories, where water analyses commenced within 24 hours of sampling.

In situ, total dissolved solids (TDS), salinity, temperature and pH were measured using a portable multimeter (PCSTestr 35, Eutech Instruments Pte Ltd. Singapore). Hach Lange DR 2800 spectrophotometer (HACH, USA) was used to measure nitrite (HACH method 8153), nitrate (HACH method 8039), phosphorous (HACH method 8178) and chemical oxygen demand (COD; HACH method 8000) according to the Manufacturer’s protocol. Physicochemical levels were compared to [23] for domestic use to determine the water quality of treated water.

DNA isolation

The environmental DNA was extracted from cellulose nitrate filters with 0.2 μm porous size (Sartorius, Germany) using the Powerwater kit (Qiagen, Netherlands) per the Manufacturer’s protocol. DNA concentrations were measured using the NanoDrop-1000 spectrophotometer (Nanodrop Technologies, USA) and where applicable, the DNA concentrations were diluted to 20 ng/μL for downstream applications.

Library preparation of next-generation sequencing for 16S rRNA amplicon libraries and sequencing

The library preparation and sequencing were done according to the Illumina (USA) manufacturer’s protocol. The locus-specific primers were linked to Illumina forward and reverse adapter overhang nucleotides sequence. The Agencourt AMPure XP beads (Beckman Coulter Genomics, USA) were used to purify amplicons after each PCR stage. The amplified PCR products were quantified by a Qubit 3.0 fluorometer (ThermoFisher, USA). The 16S rRNA libraries were pooled, denatured (0.2 N NaOH) and pair-end sequenced (2×300 bp) on the Illumina Miseq platform (Illumina, USA).

16S rRNA GENE metabarcoding analysis

Raw data sequence files were exported to QIIME2 version 2022.2 to de-multiplex, remove poor-quality sequences, and trim adaptor and primer sequences using the DADA2 pipeline. Furthermore, the DADA2 pipeline was used for clustering and taxonomic classification of operational taxonomic units (OUTs) with a 97% identity threshold—the SILVA 132 database to align the sequences. The sequences were then normalized and sequences read ranged between 47 911 and 86 187 counts per sample.

Microorganisms belonging to domain bacteria were exported to Microsoft Excel and MicrobiomeAnalyst for downstream analyses [24]. Microsoft Excel was used to construct stacked columns for bacterial phyla and genera. MicrobiomeAnalyst was used to calculate the alpha diversity based on the Shannon index (species diversity and evenness), Simpson index (species dominance) and Chao1 and ACE estimator (richness) [24].

Screening of antibiotic resistance genes

The eDNA was subjected to the end-point PCR for screening the presence of ARGs such as ermF, ermB, sul1, sul2, intI1, ampC BlaTEM and plasmid-mediated AmpC β-lactamase genes (pAmpCs including DHA, MOX, FOX, CIT, ACC and EBC). Each gene had a PCR reaction mixture consisting of 9.5 μl nuclease-free water (Fermentas Life Sciences, US), 12.5 μL DreamTaq PCR master mix (Thermo Scientific, US), 1 μL of each oligonucleotide primer and 1 μL of DNA template. Furthermore, a no template control of each gene was also included. The oligonucleotide primers, amplification size and PCR cycling conditions are shown in S1 and S2 Tables.

Quantification of 16s rRNA and antibiotic resistance genes

The absolute quantification of ARGs was conducted using the method described by [25] for pAmpCs, and [26] for 16S rRNA, sul1 and intl1 genes. Each gene consisted of a 10 μL reaction mixture volume in accordance with the PowerUp SYBR Green Master Mix manufacturer’s protocol (Applied Biosystems, Thermo Fisher Scientific, Lithuania) by using the QuantStudio 3 platform (Applied Biosystems, Thermo Fisher Scientific, USA). The 16S rRNA, sul1 and intl1 genes oligonucleotide primers, amplification size and PCR cycling conditions are shown in S3 Table. The FAM fluorescent dye TaqMan gene expression assays (Thermo Fisher Scientific, USA) were used for the quantification of DHA (Ba04646120_s1), FOX (Ba04646126_s1), ACC (Ba04646144_s1), CIT (Ba04646135_s1), MOX (Ba04646156_s1) and EBC genes (Ba04646124_s1) using TaqMan’s default cycling conditions.

Solid-phase extraction and ultra-performance liquid chromatography

A quantity of 1 g of Na2EDTA was added to 1 L of the samples before the extraction and the pH was adjusted to 2 with 32% HCl (Rochelle Chemicals, RSA). The HLB-H disks (Atlantic disk, USA) and an automated SPE-DEX system (Horizon Technology, Salem, NH, USA) were used for the extraction of antibiotics and fluconazole. The HLB-H disks were conditioned with methanol, ultrapure water and ultrapure water of pH 2. Samples were washed with ultrapure water and rinsed with methanol and Acetone/Methanol (1:1). The elutes were evaporated to dryness under a gentle stream of nitrogen gas within a water bath of 37°C and the residues were dissolved in 1 ml of methanol- Milli-Q water (1:1) and 0.1% formic acid.

The analyses of antibiotics and fluconazole were performed on ultra-high-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS) system. Antibiotic and fluconazole were separated using a Poroshell Bonus-RP 120 (2.1×100mm; 2.7 μm) column (Agilent Technologies, USA). The mobile phase consisted of 0.1% formic acid in Milli-Q water (A) and 0.1 formic acid in acetonitrile (B). The gradient elution was 0–2.0 min, 5% B with 0.2 mL/min flow rate; 2.0–5.55 min, 15% B with 0.4 mL/min flow rate; 5.55–11.10 min, 20% B with 0.2 mL/min flow rate; 11.10–13.15 min, 25% B with 0.6 mL/min flow rate; 13.15–17.20 min, 35% B with 0.2 mL/min flow rate; 17.20–20.0 min, 100% B with 0.2 mL/min flow rate; 20.0–22.0 min, 5% B with 0.2 mL/min flow rate. The mass spectrometry parameters were drying gas temperature 250ºC, drying gas flow 8 L/min, nebulizer pressure 20 psig, sheath gas flow 7.5 L/min, VCap 3 000 V, nozzle voltage 0 V, fragmentor 130 V, skimmer 70 V and Oct 1 RF Vpp 750 V with positive electrospray ionization.

Quality control and analytical performance

The method for antibiotic and fluconazole was validated by determining the matrix effects, linearity, limits of quantification (LOQ), limits of detection (LOD), accuracy and precision [27]. The linearity of a matrix-matched calibration curve was verified by spiking the matrix with known concentrations of antibiotics and fluconazole (ranging from 0 to 10 μg/L, depending on the target compound). The following equations calculated the LOQ and LOD:

LOD=3*Sdm
LOQ=10*Sdm

Where: Sd = standard deviation

m = slope

The measurements for inter-day precision were performed by calculating the ratio of the standard deviation and average of the six replicates across three days. The intra-day precision was also determined [27]. The method’s accuracy was determined by spiking a matrix with known low, medium and high fluconazole and antibiotic concentrations to determine the recovery. The linear equation (y = mx + c) was used to calculate the concentrations to determine the abundance ratio. Furthermore, this equation was to determine unknown concentrations of water samples. Measurements of samples were performed in triplicates.

Risk quotient

Data generated from the chemical analysis was used to calculate the risk quotient (RQ) based on the method described by [15, 28]. Furthermore, the fluconazole RQ was based on the environmental predicted no-effect concentration (PNEC-ENV) values reported by [29]. The RQ ≥1 denotes high risk, <1 denotes medium risk and <0.1 denotes low risk. The RQ is calculated using the following equation:

RQ=CPNEC

Where: RQ = Risk quotient

C = measured antibiotic concentration

PNEC-ENV = environmental predicted no-effect concentration

Statistical analyses

The R software (version 4.1.3) was used for statistical analyses. Shapiro–Wilk test was performed to determine the normality of the data. If the data failed the normality test, the Wilcoxon test was performed to determine whether there were statistically significant differences between raw and treated water of each DWPF. The student’s t-test was performed if data were normally distributed. The data between raw and treated water was considered significant when the p-value was <0.05. The correlation between bacterial communities and environmental factors was determined using Redundancy analysis (RDA) using Canoco Software (Version 4.5) and pairwise correlation matrices using Statistica Software (Version 14.0.1.25). Significant differences were established at p-value <0.05. Furthermore, correlations were based on the end-point PCR analysis data [25].

Results

Method validation

The ARGs and 16S rRNA method was validated for amplification linearity and efficiency. The serial dilution method with known number of copies was used to construct standard curves. The standard curves had determination efficiency (R2) >0.97 and efficiencies ranging between 90% to 110%. These parameters were regarded as reliable for determining unknown concentrations of genes in water samples [25].

Table 1 shows the parameter for method validation of antimicrobial residues. The linearity was above 0.99, LOD and LOQ ranges were 0.04–0.34 μg/L and 0.13–1.14 μg/L, respectively. The relative standard deviation (RDS) of inter-day and intraday precisions ranged between 1.09 and 19.92 μg/L. The accuracy determined by the recovery was between 90% and 102%.

Table 1. Method validation parameters for the quantification of antimicrobial residues.

Target residues LOD (μg/L) LOQ (μg/L) R 2 Intra-day precision (%RSD) Inter-day precision (%RSD) Recovery (%)
Day 1 Day 2 Day 3
Ampicillin 0.24 0.79 0.999 5 4 5 5 90
Trimethoprim 0.04 0.13 0.994 3 1 3 11 101
Ciprofloxacin 0.11 0.36 0.998 4 2 3 13 102
Sulfamethoxazole 0.34 1.14 0.997 6 9 2 20 93
Fluconazole 0.30 1.01 0.999 5 2 1 19 98

R2 = R square; LOD = limit of detection; LOQ = Limit of quantification; RSD = relative standard deviation.

Physicochemical parameters analysis

Tables 2 to 4 show the physicochemical parameters measured in NW-E and NW-C DWPFs. In the current study, higher TDS, salinity, phosphate, nitrate, nitrite and COD levels were anticipated in raw than in treated water of NW-E and NW-C DWPFs. In NW-E DWPF, this was the case for levels of TDS (raw water = 549.69 mg/L and treated water = 548.50 mg/L), salinity (raw water = 342.06 mg/L and treated water = 340.25 mg/L), phosphate (raw water = 6.48 mg/L and treated water = 1.73 mg/L), nitrate (raw water = 0.85 mg/L and treated water = 0.80 mg/L) and nitrite (raw water = 2.44 mg/L and treated water = 1.67 mg/L), as shown in Tables 2 and 4. Significant differences (p-value <0.05) existed between raw and treated water for phosphate and nitrite levels. However, it was not the case for the COD, which was slightly higher in treated (13.00 mg/L) than in raw water (11.33 mg/L). Significant differences in COD levels were not determined due to a lack of replicates.

Table 2. Physical parameters with standard deviations measured in 2020, 2021 and 2022 in raw and treated water of NW-E DWPF.

Date Sites TDSs (mg/L) pH Salinity (mg/L) Temperature (°C)
DWAF (1996a) ≤450 ≥6.0 to ≤9.0 ≤100 -
Dec 2020 Raw inlet 1 643.00±1.00 8.20±0.05 306.67±0.58 23.10±0.10
Raw inlet 2 670.67±0.67 8.35±0.02 322.00±0.00 22.83±0.06
Treated water 651.67±2.08 7.90±0.02 311.33±1.53 23.40±0.66
Feb 2021 Raw inlet 1 619.67±1.65 8.44±0.15 302.67±0.58 24.10±0.20
Raw inlet 2 646.33±0.58 8.02±0.04 315.33±0.58 23.60±0.00
Treated water 633.33±1.53 7.87±0.00 304.33±0.58 24.37±0.38
Jul 2021 Raw inlet 1 524.67±1.53 9.38±0.02 353.00±1.00 13.27±0.21
Raw inlet 2 543.00±2.00 9.39±0.06 360.67±0.58 10.33±0.32
Treated water 532.00±1.00 8.96±0.01 357.67±0.58 12.13±0.47
Aug 2021 Raw inlet 1 527.00±1.00 8.55±0.01 356.33±0.58 14.27±0.25
Raw inlet 2 549.00±1.00 8.30±0.03 370.67±0.58 14.10±0.46
Treated water 528.00±1.00 8.41±0.02 356.00±1.00 13.87±0.35
Sep 2021 Raw inlet 1 529.00±2.65 8.58±0.03 361.33±0.58 17.80±0.20
Raw inlet 2 543.67±1.53 8.40±0.01 371.33±0.58 17.67±0.42
Treated water 533±0.67 8.36±0.02 369.67±3.79 17.87±0.15
Dec 2021 Raw inlet 1 484.33±0.58 8.41±0.03 331.67±1.53 22.90±0.10
Raw inlet 2 488.67±1.15 7.84±0.02 332.67±1.15 20.77±0.67
Treated water 486.67±1.15 8.09±0.02 333.67±1.53 22.10±0.26
Feb 2022 Raw inlet 1 499.33±0.58 8.09±0.04 342.33±0.58 21.57±0.06
Raw inlet 2 510.00±1.00 7.98±0.02 348.67±2.52 22.43±0.15
Treated water 505.33±0.33 7.84±0.01 344.67±0.58 22.33±1.53
Mar 2022 Raw inlet 1 512.67±0.58 8.34±0.01 350.00±0.00 19.40±1.15
Raw inlet 2 506.67±0.58 8.23±0.01 346.67±0.58 20.30±0.20
Treated water 517.67±0.58 8.17±0.01 353.67±0.58 19.90±0.10

TDSs- total dissolved solids; “-“–not specified

Table 4. Chemical parameters with standard deviations measured in 2021 and 2022 in raw and treated water of NW-E and NW-C DWPFs.

Date Sites Phosphate (mg/L) Nitrates (mg/L) Nitrites (mg/L) COD (mg/L)
DWAF (1996a) - ≤6 ≤6 -
Feb 2021 NW-E Raw inlet 1 2.69±0.53 0.87±0.15 3.00±0.00 0.00
Raw inlet 2 2.37±0.34 0.77±0.42 2.33±1.15 18.00
Treated water 2.67±0.68 1.00±0.17 2.00±0.00 16.00
NW-C Raw inlet 1.25±0.22 1.67±0.12 1.00±0.00 85.00
Treated water 3.37±0.84 1.83±0.32 2.00±1.00 4.00
Sep 2021 NW-E Raw inlet 1 3.51±0.84 0.73±0.06 2.00±0.00 13.00
Raw inlet 2 4.48±2.09 0.60±0.00 3.00±0.00 8.00
Treated water 2.40±0.23 0.57±0.12 1.00±0.00 14.00
NW-C Raw inlet 3.93±0.58 1.77±0.06 2.00±0.00 4.00
Treated water 3.43±1.32 1.80±0.00 1.00±0.00 6.00
Mar 2022 NW-E Raw inlet 1 20.08±0.12 1.03±0.15 1.33±1.15 13.00
Raw inlet 2 5.74±2.25 1.07±0.06 3.00±0.00 16.00
Treated water 1.06±0.84 0.83±0.32 2.00±0.00 9.00
NW-C Raw inlet 5.29±2.32 0.93±0.15 4.33±1.15 4.00
Treated water 5.82±3.100 2.30±0.87 2.00±1.00 5.00

COD–Chemical oxygen demand; “-“–not specified

In NW-C DWPF, the anticipated results were true for nitrite (raw water = 2.33 mg/L and treated water = 1.67 mg/L) and COD (raw water = 31.00 mg/L and treated water = 5.00 mg/L), as shown in Table 4. No significant differences existed for the nitrite levels. The anticipation was not true for the levels of the TDS (raw water = 406.25 mg/L and treated water = 409.00 mg/L), salinity (raw water = 250.38 mg/L and treated water = 252.75 mg/L), phosphate (raw water = 3.47 mg/L and treated water = 4.21 mg/L) and nitrate (raw water = 1.46 mg/L and treated water = 1.98 mg/L). Only nitrate levels were significantly (p-value <0.05) higher in treated compared to raw water.

Temperature fluctuated between raw and treated water in NW-E and NW-C. In NW-E, the temperature range was between 10.3°C and 24.1°C. In NW-C, the range was between 13.6°C and 20.9°C. (Tables 2 and 3). The pH was higher in raw than in treated water in both NW-E and NW-C. In NW-E, pH ranged from 7.84 to 9.39, with significant differences (p-value <0.05) between raw and treated water (Table 2). In NW-C, water samples had a pH range of 7.86 and 8.1, with no significant differences (p-value >0.05) between raw and treated water (Table 3).

Table 3. Physical parameters with standard deviations measured in 2020, 2021 and 2022 in raw and treated water of NW-C DWPF.

Date Sites TDSs (mg/L) pH Salinity (mg/L) Temperature (°C)
DWAF (1996a) ≤450 ≥6.0 to ≤9.0 ≤100 -
Dec 2020 Raw inlet 478.67±1.15 8.10±0.04 232.00±0.00 20.47±0.35
Treated water 476.33±2.08 7.94±0.01 231.33±0.58 20.87±0.21
Feb 2021 Raw inlet 483.33±0.58 8.15±0.05 233.33±0.58 20.07±0.06
Treated water 490.67±0.58 7.89±0.01 236.33±0.58 18.77±0.21
Jul 2021 Raw inlet 378.00±2.00 9.31±0.03 249.33±1.15 13.63±0.31
Treated water 381.67±3.21 9.28±0.06 254.00±1.00 13.80±0.40
Aug 2021 Raw inlet 381.67±0.58 8.29±0.01 256.00±1.00 15.93±0.06
Treated water 382.67±0.58 8.22±0.03 257.67±0.58 17.33±0.06
Sep 2021 Raw inlet 378.33±1.15 8.36±0.03 254.00±1.00 15.83±0.25
Treated water 371.67±9.29 8.35±0.03 255.33±1.15 15.07±0.15
Dec 2021 Raw inlet 381.33±0.58 8.20±0.01 259.67±0.58 19.87±0.15
Treated water 389.00±1.00 8.25±0.02 263.33±1.15 19.63±0.31
Feb 2022 Raw inlet 386.67±0.58 8.15±0.02 262.00±1.00 17.80±0.20
Treated water 391.67±0.58 8.12±0.02 264.00±0.00 18.23±0.31
Mar 2022 Raw inlet 382.00±0.00 8.34±0.01 257.00±0.00 15.67±0.06
Treated water 386.67±0.58 8.16±0.01 260.67±0.58 16.47±0.58

TDSs- total dissolved solids; “-“–not specified

The physicochemical parameters were compared to the [23] for domestic water use. In NW-E treated water, pH, nitrate and nitrite levels were within the target water quality range of [23]. However, salinity and TDS levels were not. These levels were 240.25 mg/L (salinity) and 98,50 mg/L (TDS) higher than the [23] values. In NW-C treated water, pH, TDS, nitrate and nitrite levels were within the target water quality range of [23]. However, salinity levels were not. These levels were 150 mg/L higher than the [23] values.

Bacterial community composition

Fig 1 represents phylum-level changes in the bacterial community composition of NW-E and NW-C DWPFs. NW-E and NW-C DWPFs had seven phyla with >2% relative abundance. The following trends were observed: In NW-E DWPF, the following phyla dominated: Proteobacteria (raw water = 38.22% and treated water = 40.22%), Bacteroidota (raw water = 20.05% and treated water = 14.71%), Acidobacteriota (raw water = 18.33% and treated water = 10.71%) and Cyanobacteria (raw water = 9.98% and treated water = 10.32%). In NW-C DWPF, the following phyla dominated: Proteobacteria (raw water = 48.50% and treated water = 50.64%), Bacteroidota (raw water = 21.99% and treated water = 14.21%) and Acidobacteriota (raw water = 7.67% and treated water = 7.49%).

Fig 1. Stacked column illustrating phylum-level changes in bacterial community composition of raw and treated water at NW-E and NW-C DWPFs.

Fig 1

Others consist of phyla with relative abundance < 2.00%.

In NW-E and NW-C DWPFs, there were 12 genera with >1% relative abundance, as shown in Fig 2. The following trends were observed: In NW-E DWPF, the following genera dominated: Comamonas (raw water = 11.84% and treated water = 5.13%), Dickeya (raw water = 6.67% and treated water = 8.47%), Nocardia (raw water = 3.72% and treated water = 5.44%) and Clade III (raw water = 5.20% and treated water = 1.42%). In NW-C DWPF, the following genera dominated: Comamonas (raw water = 16.28% and treated water = 5.57%), Dickeya (raw water = 9.91% and treated water = 10.09%), Allorhizobium-Neorhizobium-Pararhizobium-Rhizobium (raw water = 9.81% and treated water = 2.03%) and Other (raw water = 3.11% and treated water = 5.73%).

Fig 2. Stacked column illustrating genus-level changes in bacterial community composition in raw and treated water of NW-E and NW-C DWPFs.

Fig 2

Others consist of genera with relative abundance < 1.00%.

The Shannon Index (species diversity and evenness), Chao1 estimator (richness), ACE estimator (richness) and Simpson index (species dominance) were calculated to determine Alpha diversity and significant differences for raw and treated water of NW-E and NW-C DWPFs as shown in Fig 3. Similar observations were made in NW-E and NW-C DWPFs in which treated water was more even, diverse and rich compared to raw water. However, more dominance was recorded for treated water in NW-C and raw water 1 for NW-E. Furthermore, no significant differences were observed (p-value >0.05) between raw and treated water.

Fig 3. Bacterial alpha diversity indices (A-ACE, B-Chao1, C-Shannon and D-Simpson) in raw and treated water of NW-E and NW-C DWPF.

Fig 3

Screening on antibiotic resistance genes

The extracted eDNA was subjected to end-point PCR for ARGs, as shown in Fig 4. Sampling sites and ARG levels are represented by circularly arranged segments whose length is proportional to the total percentage values of ARGs. The outer rings with percentages are stacked bar plots representing a cell’s relative contribution to ARG levels. Ribbons between ARG and sampling sites represent the detection percentages. This section focused on the ribbons representing the length of the total percentage values of ARGs in different sampling sites. In NW-E DWPF, the number of samples that were positive for ampC, blaTEM, intl1 and sul1 genes was higher in raw than in treated water samples. However, more sul2 positive samples were in treated water (75.00%) compared to raw water (70.83%). Furthermore, a similar number of positive samples for ermB (41.67%) and ermF (58.33%) genes was observed in raw and treated water.

Fig 4. Chord diagram illustrating the end-point PCR screening process of ARGs in raw and treated water of NW-E and NW-C DWPFs.

Fig 4

In NW-C DWPF samples, intl1, ermB and sul2 genes were detected in larger numbers in raw water compared to treated water samples (Fig 4). However, sul1 gene was detected in higher numbers of samples of treated water (45.45%) compared to raw water (40.00%). Furthermore, the ermF gene was detected in similar numbers in raw and treated water samples (54.44%). The ampC and blaTEM genes were not in raw and treated water samples of NW-C DWPF.

A general trend was observed in which pAmpCs such as ACC, MOX, FOX and EBC were detected in more raw samples compared to treated water samples in NW-E and NW-C DWPF (Fig 4). The DHA gene detection was detected in more treated water samples of NW-E DWPF than NW-C DWPF. Another trend observed was the absence of the CIT gene in raw and treated water samples of NW-E and NW-C DWPFs.

Quantification of antibiotic resistance genes

Table 5 represents the concentrations and standard deviation of pAmpCs, intl1 and sul1 genes in DWPFs. This was determined according to [25] for pAmpCs, [24]. However, samples in which these ARGs were not detected during the end-point PCR screening process were excluded. The sul1 concentrations were higher in treated water of NW-E and NW-C DWPFs. In NW-E, the sul1 concentrations were 3.73×10−4 copies/16S rRNA in treated water and 2.53×10−4 copies/16S rRNA in raw water. In NW-C, the sul1 concentrations were 6.03×10−2 copies/16S rRNA in raw water and 7.97×10−2 in treated water.

Table 5. Concentrations of ARGs in raw and treated water of NW-E and NW-C DWPFs (units in gene copies/16S Rrna ± standard deviation).

Sites EBC ACC CIT DHA MOX FOX IntI1 Sul1
NW-E Raw water 1 2.15×10−2 ±2.68×10−2 2.68×10−1 ±2.31×10−1 - 2.26×10−2 ±3.62×10−2 1.29×10−1 ±2.03×10−1 1.04×100 ±7.65×10−1 2.03×10−4 ±7.22×10−5 1.95×10−3 ±1.43×10−3
Raw water 2 5.23×10−2 ±1.46×10−2 4.79×10−2 ±1.38×10−2 - 4.18×10−3 ±1.81×10−3 - 2.01×10−1 ±1.28×10−1 5.76×10−4 ±9.99×10−4 3.10×10−3 ±3.63×10−3
Treated water 6.37×10−2 ±2.27×10−2 7.32×10−2 ±1.57×10−1 - 4.16×10−2 ±1.70×10−2 - 4.12×10−1 ±6.49×10−1 6.12×10−4 ±3.76×10−4 3.73×10−3 ±1.04×10−3
NW-C Raw water 7.67×10−2 ±2.33×10−2 3.85×10−2 ±1.60×10−2 - - - 1.44×101 ±1.33×101 3.50×10−4 ±1.89×10−6 6.03×10−2 ±2.02×10−2
Treated water - <LOD - - - 6.94×10−2 ±1.42×10−1 ND 7.97×10−2 ± .81×10−2

LOD–limit of detection; ND–not done; “-“–not detected by end-point PCR

In NW-E DWPF, the EBC concentrations were higher in treated water (6.37×10−2 copies/16S rRNA) than in raw water (6.37×10−2 copies/16S rRNA), as shown in Table 5. In NW-C DWPF, the EBC concentrations were 7.67×10−2 copies/16S rRNA in raw water. However, treated water was not subjected to real-time PCR analysis because it was not detected during the screening using end-point PCR.

In NW-E DWPF, the ACC concentrations in treated water were 7.32×10−2 copies/16S rRNA and 1.58×10−1 copies/16S rRNA in raw water (Table 5). This was inconsistent with the finding obtained in NW-C DWPF, where the ACC concentrations were higher in raw water (3.85×10−2 copies/16S rRNA) than in treated water (<LOD).

In NW-E DWPF, the DHA concentrations were higher in treated water (4.16×10−2 copies/16S rRNA) compared to raw water (1.34×10−2 copies/16S rRNA), as shown in Table 5. Since the DHA gene was not detected during the end-point PCR screening process in raw and treated water, it was not subjected to real-time PCR analysis.

In NW-E DWPF, the intl1 concentrations were higher in treated water (6.12×10−4 copies/16S rRNA) than in raw water (3.90×10−4 copies/16S rRNA). In NW-C DWPF, the intl1 concentrations were 3.50×10−4 copies/16S rRNA in raw water. However, the intl1 concentrations of treated water were not determined due to insufficient eDNA.

The FOX concentrations were higher in raw water of NW-E and NW-C DWPFs. In NW-E, the FOX concentrations in 4.12×10−1 copies/16S rRNA in treated water and 6.22×10−1 copies/16S rRNA in treated water (Table 5). In NW-C DWPF, the FOX concentrations were 6.94×10−2 copies/16S rRNA in treated water and 1.44×101 copies/16S rRNA in treated water.

In NW-E, the MOX concentrations were 1.29×10−1 copies/16S rRNA in raw water 1 (Table 5). However, the MOX concentrations were not determined in raw water 2 and treated water of NW-E due to its absence during the end-point PCR screening process. The MOX concentrations were also determined in NW-C raw and treated water. Furthermore, the CIT concentrations in NW-E and NW-C were not determined for the above reasons.

Quantification of antibiotic residues

The antimicrobial concentrations (μg/L) and standard deviations are shown in Tables 6 and 7. In NW-C DWPF, ampicillin, ciprofloxacin, sulfamethoxazole and fluconazole concentrations were higher in raw than treated water. However, trimethoprim concentrations were higher in treated than in raw water. In NW-E DWPF, all target compound concentrations were higher in raw than treated water. Furthermore, in NW-E and NW-C DWPFs, no significant differences (p-value >0.05) existed between raw and treated water.

Table 6. Concentrations with standard deviations of target antimicrobial residues in raw and treated water of NW-E DWPF.

Date Sampling sites Ampicillin (μg/L) Ciprofloxacin (μg/L) Sulfamethoxazole (μg/L) Trimethoprim (μg/L) Fluconazole (μg/L)
Oct-20 Raw inlet 1 5.95±0.84 3.43±0.41 3.46±0.52 <LOQ <LOQ
Raw inlet 2 12.97±0.12 4.91±0.73 3.78±0.13 <LOQ <LOQ
Treated water 8.10±0.85 3.42±0.28 2.85±0.49 <LOQ <LOQ
Nov-20 Raw inlet 1 8.90±1.13 <LOQ 1.53±0.37 0.18±0.00 <LOQ
Raw inlet 2 11.55±2.09 <LOQ <LOQ <LOQ <LOQ
Treated water 11.53±4.15 <LOQ <LOQ 0.19±0 <LOQ
Dec-20 Raw inlet 1 16.85±3.45 0.95±0.18 2.03±0.37 0.82±0.04 <LOQ
Raw inlet 2 24.58±4.59 0.74±0.23 2.00±0.13 0.24±0.01 <LOQ
Treated water 12.56±0.37 0.83±0.18 <LOQ 0.20±0.01 <LOQ
Feb-21 Raw inlet 1 25.81±1.81 2.25±0.05 <LOQ <LOQ <LOQ
Raw inlet 2 11.79±2.37 2.83±0.74 <LOQ 0.17±0.03 <LOQ
Treated water 10.02±0.04 0.60±0.04 <LOQ <LOQ <LOQ
Jul-21 Raw inlet 1 4.20±0.17 1.32±0.20 <LOQ 0.40±0.03 <LOQ
Raw inlet 2 6.10±2.34 0.87±0.01 <LOQ 0.22±0.02 <LOQ
Treated water 2.83±0.38 0.55±0.07 <LOQ 0.25±0.01 <LOQ
Aug-21 Raw inlet 1 27.77±1.29 1.37±0.30 <LOQ 0.40±0.01 <LOQ
Raw inlet 2 11.92±0.06 <LOQ <LOQ <LOQ <LOQ
Treated water 3.27±0.10 1.00±0.06 <LOQ 0.39±0.05 <LOQ
Feb-22 Raw inlet 1 18.89±3.81 46.52±1.47 2.64±0.26 0.35±0.02 9.49±0.78
Raw inlet 2 20.08±3.68 0.44±0.00 1.65±0.12 0.33±0.01 19.03±5.78
Treated water 14.18±3.81 0.75±0.09 2.64±0.12 0.32±0.04 8.34±1.50

LOQ–limit of quantification

Table 7. Concentrations with standard deviations of target antimicrobial residues in raw and treated water of NW-C DWPF.

Date Sites Ampicillin (μg/L) Ciprofloxacin (μg/L) Sulfamethoxazole (μg/L) Trimethoprim (μg/L) Fluconazole (μg/L)
Nov-20 Raw inlet 16.93±3.69 <LOQ <LOQ 0.16±0.01 <LOQ
Treated water 15.72±0.08 <LOQ <LOQ 0.16±0.03 <LOQ
Dec-20 Raw inlet 5.04±0.41 <LOQ 3.51±0.14 <LOQ <LOQ
Treated water 3.91±1.34 <LOQ 2.64±0.95 0.25±0.05 <LOQ
Feb-21 Raw inlet 10.50±2.06 2.42±0.27 <LOQ <LOQ <LOQ
Treated water 7.08±1.29 2.08±0.28 <LOQ <LOQ <LOQ
Jul-21 Raw inlet 2.48±0.95 0.56±0.07 <LOQ 0.24±0.03 <LOQ
Treated water 2.43±0.76 <LOQ <LOQ 0.21±0.02 <LOQ
Aug-21 Raw inlet 2.75±0.09 <LOQ <LOQ <LOQ <LOQ
Treated water 3.15±0.09 <LOQ <LOQ <LOQ <LOQ
Feb-22 Raw inlet 6.65±0.65 1.09±0.06 2.17±0.05 <LOQ 27.71±9.06
Treated water 7.45±0.15 1.09±0.06 1.91±0.31 <LOQ 13.84±1.12

LOQ–limit of quantification

In DWPFs, ampicillin concentrations were higher in raw water (NW-E range between 4.20 and 27.77 μg/L and NW-C range between 2.48 and 16.93 μg/L) than in treated water (NW-E range between 2.83 and 14.19 μg/L and NW-C range between 2.43 and 15.72 μg/L). However, in November 2020, in NW-E, ampicillin concentrations were higher in treated water (11.53 μg/L) than in raw water (10.23 μg/L). In NW-C, higher ampicillin concentrations in treated water were also measured in August 2021 and February 2022.

In NW-C DWPF, ciprofloxacin concentrations were 0.68 μg/L in raw water and 0.53 μg/L in treated water. In February 2022, ciprofloxacin concentrations were 1.09 μg/L in raw and treated water of NW-C (Table 7). In NW-E DWPF, ciprofloxacin concentrations were 4.69 μg/L in raw water and 1.02 μg/L in treated water (Table 6).

Sulfamethoxazole concentrations were 1.22 μg/L in raw water and 0.78 μg/L in treated water in NW-E DWPF (Table 6). However, in February 2022, sulfamethoxazole concentrations were higher in treated water (2.64 μg/L) than in raw water (2.15 μg/L). In NW-C DWPF, sulfamethoxazole concentrations were 0.95 μg/L in raw water and 0.75 μg/L in treated water (Table 7).

In NW-E DWPF, trimethoprim concentrations were higher in treated water in November 2020 and August 2021 (Table 6). Overall, trimethoprim concentrations were higher in raw water (0.20 μg/L) than in treated water (0.19 μg/L). Contrary, in NW-C DWPF, trimethoprim concentrations were higher in treated water (0.10 μg/L) than in raw water (0.07 μg/L), as shown in Table 7.

In NW-E and NW-C DWPFs, fluconazole concentrations were <LOQ from October 2020 until August 2021 (Tables 6 and 7). In February 2022, fluconazole concentrations were 14.26 μg/L in raw water and 8.34 μg/L in treated water in NW-E DWPF. Furthermore, in NW-C DWPF, fluconazole concentrations were 27.71 μg/L in raw water and 13.84 μg/L in treated water.

Risk quotient

The risk quotients of raw and treated water in NW-E and NW-C DWPFs are shown in Fig 5. A general trend observed in NW-E and NW-C DWPFs was that the RQ of sulfamethoxazole, ampicillin and ciprofloxacin was ≥1 in both raw and treated water. However, the RQ of ciprofloxacin in NW-C treated water which was <1. In NW-E, fluconazole was <1 in raw and treated water; in NW-C, it was <0.1 in both water types. Another trend observed was the RQ of trimethoprim was <0.1 in NW-E and NW-C.

Fig 5. Heatmap of risk quotients (RQs) in raw and treated water of NW-E and NW-C DWPFs.

Fig 5

Correlation of bacterial communities with ARGs, antibiotics and physicochemical parameters in drinking water production facilities

The RDA correlation of bacterial communities with physicochemical parameters, ARGs and antimicrobial residues is shown in Fig 6. Initially, commonly prescribed antimicrobial agents and prevalent ARGs were included in the analysis [6]. However, due to the failed optimization for screening ARGs and quantifying antimicrobial residues, only a few parameters were included in the current study. The results revealed no significant correlation (p-value >0.05) in the first and other canonical axes. Furthermore, the pairwise correlation between bacterial communities and environmental factors is shown in S1 Appendix. Dickeya and Armatimonas were significantly correlated (p-value <0.05) with the ampC gene. CL500-29 marine group had a significant correlation (p-value <0.05) with phosphate, pH, MOX gene, ACC gene, sulfamethoxazole and ciprofloxacin levels. Clade III significantly correlated with the BlaTEM gene, ACC gene and ampicillin. Zymomonas significantly correlated (p-value <0.05) with ermB and intl1 genes.

Fig 6. RDA of correlation between (A) bacterial community composition, physicochemical parameters, ARGs and antibiotic residues in raw and treated water of NW-E and NW-C DWPFs.

Fig 6

FCZ–fluconazole; temp–temperature; AMP–ampicillin; sal–salinity; COD–Chemical oxygen demand, TDS–Total Dissolved Solids; SMX–Sulfamethoxazole; NO2—nitrite, NO3—nitrate; PO4 –phosphate; TMP–trimethoprim.

Discussion

In NW-C DWPFs, the phosphate and nitrate levels were higher in treated than in raw water. This is attributable to the operations and configuration of NW-C DWPF, specifically, the sump used to collect water after filtration. The water is not suspended long enough to settle suspended solids. This was not the case in the DWPF situated NW-E. Furthermore, in Bayas, Ecuador [30] and Kafr El-Shinawy, Egypt [31], phosphate and nitrate levels are always lower in treated water. The latter studies focussed on the water quality of raw and treated water.

The nitrite levels were higher in raw compared to treated water of NW-E (p-value <0.05) and NW-C (p-value >0.05) DWPFs. The findings of NW-E DWPFs could be attributed to the sedimentation process that allows suspended particles to settle out [32]. Similar nitrite trends in which nitrite levels decreased from raw to treated water were also observed in Jiangsu Province, China and Kafr El-Shinawy, Damietta, Egypt [31]. Overall, the nitrate and nitrite levels measured in NW-E and NW-C DWPFs were within the target water quality range (0–6 mg/L) of [23] for domestic use. However, the phosphate, nitrate and nitrite may promote bacterial growth and microbial growth from treated water to distribution networks [10].

Consistent with [12], TDS levels were higher in treated water than in raw water in NW-C DWPF. These levels indicate that water might be objectionable due to its flat, insipid taste [23]. Consistent with [33], in NW-E and NW-C DWPF, salinity levels were higher in raw than treated water. However, higher TDS and salinity levels in NW-E were attributed to the area’s geology. This DWPF is in the dolomitic region [34]. Generally, consumption of NW-E and NW-C treated water may have a noticeable salty taste which may be displeasing for people on a sodium-redistricted diet [23].

In NW-E DWPF, the COD levels were higher in treated water than in raw water. The opposite was true for the NW-C DWPF. COD levels indicate the dissolved oxygen needed to oxidize organic matter [35]. Temperature variation in NW-E and NW-C may also contribute to the growth of heterotrophic bacterial populations [10, 36]. Temperatures were typically between 15 and 25°C. Furthermore, the pH of treated water in NW-E and NW-C was considered alkaline, which is not uncommon in the North West Province of South Africa [12]. Overall, the pH recorded in the current study was within the target water quality range (6.0–9.0) of [23] for domestic use. It was important to achieve 8.00 to ensure optimum pH [35].

Treated water of NW-E and NW-C has no adverse human health effects and, thus, is safe for human consumption [23]. However, raw and treated water’s temperature, nutrients and pH may favour microbial survival [10, 12].

Consistent with other studies, Proteobacteria was the most dominant phylum in NW-E and NW-C [18, 19, 3739]. Comamonas and Dickeya genera were the dominant genera of Proteobacteria. Generally, Comamonas are not human pathogens [40]. However, consumption of treated water in NW-E and NW-C may put immunocompromised at risk since they are likely to contract bacteremia caused by some Comamonas species [41, 42].

Irrigation of crops with NW-E and NW-C raw water may transmit Dickeya to plants since these are plant pathogens, thus leading to an economic loss of important crop plants. Furthermore, Dickeya species are part of the top 10 phytopathogen bacteria [43, 44].

Genera of phylum Bacteroidota were assigned as others or unclassified despite being the second abundant phylum. Genera belonging to Bacteroidota, such as Bacteroides, are considered human pathogens with an estimated mortality rate of 19% [45].

In NW-E and NW-C DWPF, the relative abundance of Firmicutes phylum was higher in treated than in raw water. This could be attributed to endospore formation that enables species belonging to Firmicutes to resist unfavourable conditions such as desiccation and environmental stress, specifically chlorination in NW-E and NW-C DWPFs [46]. Firmicutes have also been reported in treated water and distribution networks of Northern China DWPF [38]. In the current study, the relative abundance of the Peptoniphilus genus belonging to Firmicutes was higher in treated water of DWPFs. Peptoniphilus species may harbour ARGs and are considered opportunistic pathogens to humans [47]. Thus, consuming Peptoniphilus through treated water may have negative human health impacts.

In NW-E DWPF, the relative abundance of Nocardia of phylum Actinomycetota was higher in treated water (5.44%) than in raw water (3.72%). The findings obtained in NW-E could be attributed to Nocardia’s ability to survive dormantly in unfavourable conditions such as exposure to chlorine [46]. Nocardia species are saprophytes and can also act as opportunistic pathogens [48].

In NW-E and NW-C, a trend was observed in which treated water was more species diverse, even and richer than raw water. Furthermore, species dominance was higher in treated water of NW-C. However, in NW-E, species dominance was the same in raw and treated water. The higher alpha diversity in treated water may be due to a higher relative abundance of bacterial communities than in raw water, which is associated with biofilm formation and bacterial regrowth in treated water [37] This was inconsistent with other studies that reported higher alpha diversity in raw than in treated water in DWPFs in China and Finland [39, 49]. Achieving low alpha diversity in treated water suggests that water is biologically stable [39], which was not the case for NW-E and NW-C.

The current study revealed the presence of core bacterial communities shared between NW-E and NW-C raw and treated water. The relative abundance of bacterial communities fluctuated between raw and treated water. Furthermore, it is important to emphasize that biofilm formation enables some bacteria to overcome unfavourable conditions posed by chlorine; hence higher Nocardia and Peptoniphilus were reported in treated water [46]. This could have resulted in higher alpha diversity in treated water of NW-E and NW-C observed in the current study. Furthermore, some bacterial communities are potential human and plant pathogens that could harbour ARGs. These could be transferred to the human populations if present in drinking water.

In NW-C DWPF, ampC and blaTEM genes were not detected. However, in NW-E DWPF, the ampC gene was detected in 18.18% of raw water samples but only in 10% of the treated samples. This was also seen in distribution networks in Manitoba, Canada [50].

The pAmpCs, blaTEM and ampC confer resistance to antibiotics belonging to the β-lactam spectrum [51]. In South Africa, β-lactam spectrum antibiotics, such as cephalosporins (15.73%) and penicillin (40.66%), constitute the highest prescribed antibiotics in private primary health care. Furthermore, South Africa tops the list of penicillin use compared to other BRICS nations, the United Kingdom and the United States of America [6]. Golsha et al. state that the presence of more than one β-lactam spectrum resistance gene, as shown in the current study, may increase antibiotic resistance since they are subjected to HGT among species in a wide range of environments [51].

FOX, EBC and ACC genes were detected raw water in NW-E and NW-C DWPFs. The MOX gene was only detected in raw water 1 in NW-E. DHA was also absent in NW-C DWPF, but it was detected in raw than treated water of NW-E DWPF. Although not extensively featured in environmental studies, these genes have been reported in various niches [13, 5254]. pAmpCs are widespread in various niches where their effects may be undesirable for human health [51] and they are underexplored in the DWPFs. Furthermore, according to the searched databases, there is a lack of information about the concentrations of pAmpCs in DWPFs that could be useful in developing quantitative risk assessments for humans and aquatic life exposure to these ARGs.

The detection of the ermF gene in NW-E (58.33%) and NW-C (54.55%) DWPFs was the same for raw and treated water. [2] reported ermF gene was detected in a larger number of treated water of DWPF in Jiaxing City, China, compared to the raw water. However, the ermB gene was detected in more treated water samples compared to raw water. [2] reported higher ermB gene detection in raw water. The ermB and ermF genes induce resistance to macrolides-lincosamides-streptogramin B antibiotics [55, 56]. The prescription of macrolides and lincosamides is 16.81% and 1.57% in South African primary healthcare [57]. Finding these genes in the drinking water ecosystems could be the result of this generous prescription of these antibiotics.

In NW-E and NW-C DWPF, sul2 gene was detected more in raw than treated water samples. Consistent with [58], sul1 gene was detected in more water samples than the sul2 gene. Sul1 and sul2 genes induce sulphonamide resistance and may pose health threats to HIV/AIDS patients who rely on sulfamethoxazole-trimethoprim to treat Pneumocystis pneumonia [2, 59, 60]. Furthermore, the sul1 gene in water serves as a gene marker for the presence of the intI1 gene [59]. Consistent with [61], the intI1 gene was detected in more raw water samples than treated water in NW-E and NW-C DWPF. The intI1 gene is associated with HGT and induction of multiple drug resistance [11, 62]. Finding these genes in the environment also indicates pollution from anthropogenic sources. Thus, the current study’s findings fill this literature gap in DWPFs by determining the distribution of AmpCs in raw and treated water. The int1 and sul1 concentrations were also determined in the current study.

The current study revealed that EBC, FOX, ACC and DHA concentrations were higher in treated than in raw water in NW-E DWPF. These were inconsistent with FOX and ACC concentrations recorded in NW-C that were higher in raw than treated water. Other pAmpCs were either absent in raw and/or treated water during the end-point PCR screening process and, as a result, excluded from the real-time PCR analysis. Thus, their distribution was not determined from raw to treated water.

In NW-E DWPF, the higher sul1 concentrations of 3.73×10−3 copies/16S rRNA were recorded in treated water and 2.53×10−3 copies/16S rRNA in raw water. Similar observations were made in NW-C, where in treated water (7.97×10−2 copies/16S rRNA), higher sul1 concentrations were recorded compared to raw water (6.03×10−2 copies/16S rRNA). These concentrations were comparable to those reported in raw water in water in Kathmandu Valley, Nepal [1], where the researchers also studied the prevalence of ARGs in drinking and environmental water sources.

The intI1 concentrations in NW-E (3.90×10−4 copies/16S rRNA) and NW-C (3.50×10−4 copies/16S rRNA) were comparable. Furthermore, the intI1 concentrations in NW-E treated water were 6.12×10−4 copies/16S rRNA. However, they were lower than those reported in the source water of Kathmandu Valley, Nepal [1]. Furthermore, the intI1 concentrations in NW-C treated water were not determined.

The current study showed that environmental settings, in addition to clinical settings, are important for monitoring ARGs. Thus, the consumption of treated water harbouring ARGs is a concern for individuals in NW-E and NW-C [11]. It is also a concern to report higher detection rates and concentrations of ARGs in treated than in raw water. This could be associated with a lack of monitoring and regulation of ARGs in treated water and DWPFs not designed to remove ARGs [61]. These free-range ARGs in drinking water systems could have negative human health impacts. It could result in expensive antibiotic therapy and extended hospitalization to treat common infections if these are caused by resistant microorganisms [4, 5].

In NW-E and NW-C DWPFs, the ampicillin concentrations were higher in raw water than in treated. However, no studies were found in the searched databases addressing ampicillin residues in DWPFs. The ampicillin concentrations recorded in NW-E and NW-C were lower than those in surface water collected in Cluj-Napoca, Romania [27]. As mentioned above, the use of β-lactam spectrum antibiotics in South Africa is high due to their importance in treating infections in neonatal, pediatric and adult patients [57, 60]. However, the effectiveness of ampicillin may be affected due to the presence of β-lactamase genes that have also been reported in the present study.

Consistent with Al-Rasheed and Al-Wihda DWPFs in Baghdad City, Iraq [63], In NW-E and NW-C DWPFs, the ciprofloxacin was lower in treated than in raw water. Ciprofloxacin, belonging to fluoroquinolones, is commonly used for the treatment of multidrug-resistant bacteria, which render resistant to other classes of antibiotics such as β-lactam, aminoglycosides and macrolide [63]. Thus, it is of great concern to report ciprofloxacin in NW-E and NW-C, where bacteria could induce its resistance.

Sulfamethoxazole concentrations were higher in raw than in treated water. A similar trend was observed in other studies [64, 65]. The presence of sulfamethoxazole in water may be attributed to the 3.16% prescription of sulphonamides in South African private primary health care [57]. However, as shown in the current study, sulfonamide resistance genes are present in treated water. This may limit the treatment options listed by [60].

Trimethoprim concentrations were higher in treated water than in raw water in NW-C DWPF. Furthermore, other studies reported reduced trimethoprim concentrations from raw to treated water in DWPFs in China [64, 66]. However, [27] reported high trimethoprim concentrations of 400 μg/L in surface water. Trimethoprim usage ranks among the highest-used antibiotics in South Africa [6]. However, due to the lack of antibiotic usage for each province, it is difficult to explain the low trimethoprim concentrations in the current study.

Generally, fluconazole concentrations were <LOQ for most sampling months NW-E and NW-C DWPFs. However, in February 2022, fluconazole concentrations were higher in raw and treated water. The spike in fluconazole concentrations in February 2022 is unknown. Fluconazole concentrations have been reported in surface water in North West Province, South Africa [7]. The latter studies focussed on antifungal agents, yeast abundance and diversity in surface water. The spread of fluconazole in the water environment may be associated with its prescription for individuals living with HIV to treat candidaemia and cryptococcal meningitis [7, 67]. Its frequent application and recalcitrance to biodegradation in conventional wastewater treatment plants may lead to its prevalence in the water environment which may pose risks to water users [7].

The current study further revealed that antimicrobial residues might pose ecological risks in addition to human health based on the RQ. Ciprofloxacin, ampicillin and sulfamethoxazole were deemed high risk in NW-E and NW-C. However, in NW-C treated water, ciprofloxacin was deemed a medium risk. These were in accordance with results obtained in Chinese and European surface water, reclaimed water and groundwater where ciprofloxacin and sulfamethoxazole were deemed high risk [14, 68, 69]. However, the ampicillin RQ of NW-E and NW-C were inconsistent with those reported in Hanoi lakes, Vietnam [15].

In NW-C DWPFs, trimethoprim and fluconazole were deemed low risk. However, in NW-E and DWPF, trimethoprim was deemed low risk and fluconazole high risk. The current study showed that the low to medium risk in treated water is not a result of the ability of DWPFs to treat antibiotics but the RQ recorded in raw water. Thus, it is important to include antifungals and antibiotics to monitor and regulate residues in water to protect ecological and human health.

Although most antimicrobial concentrations were lower in treated than raw water, no significant differences were observed (p-value >0.05). This may be due to the design of NW-E and NW-C not accounting for the removal of antimicrobial residues. The presence of these target compounds in subinhibitory concentrations may induce antibiotic resistance, as shown by the presence of ARGs in the current study. Since there is a high number of immunocompromised patients in South Africa, the effect of antibiotic resistance may be more severe [8]. Considering that ARGs may be spread through environmental settings, monitoring and regulating antibiotic and antifungal residues in water is important to reduce the spread of antimicrobial resistance through the food chain.

Antibiotic residues, physicochemical parameters and ARGs might prompt the selection of the appropriate bacterial community and subsequently change the microbial composition and diversity [70, 71]. No significant differences (p-value >0.05) were observed between bacterial communities and environmental factors using RDA analyses. However, this contrasted with the results obtained for pairwise correlation matrices. The kind of significant correlation (p-value <0.05) observed in the current study between bacterial communities and antibiotic residues led to the speculation that various responses of bacterial communities to antibiotic residues in the environment select for antibiotic resistance in opportunistic bacteria [70]. Consistent with other studies, the correlation between bacterial communities and ARGs observed in the current study indicates that bacteria are the major sources and spreaders of ARGs [70, 71]. The physicochemical parameters in NW-E and NW-C DWPF create favourable conditions for the survival of bacteria and may directly or indirectly influence the variation and levels of ARGs [72]. The operational activities of DWPF affect physicochemical parameters and bacterial communities, thus leading to a shift in alpha diversity from raw to treated water.

Conclusion

The current study demonstrated the presence and levels of antibiotic resistance genes and antibiotic residues in two drinking water production facilities (NW-E and NW-C) in the North West Province, South Africa. It also shows how bacterial communities’ composition is linked to ARGs, antibiotic residues and physicochemical parameters. This study also demonstrated that ARGs, antibiotic residues and fluconazole (antifungal agent) pollute and may affect water quality. Yet, ARGs and antimicrobial agents are not routinely monitored and regulated in DWPFs. This has led to unknown amounts of ARGs, and antibiotic residues being spread to consumers via the drinking water chain. Thus, inducing antibiotic resistance and posing public health to consumers, especially immunocompromised people. The effects of antibiotic resistance could have dismal effects in South Africa since there is a high number of PLWH (with 13.7% of the population infected with HIV/AIDS) and dilapidating public health care facilities [8]. Furthermore, some of these pollutants pose ecological risks. Thus, including environmental studies such as this one for policymaking in combating antibiotic resistance is of utmost importance.

Supporting information

S1 Table. Oligonucleotide primers for the end-point PCR amplification of ampC, blaTEM. IntI1, ermB, ermF, Sul1 and Sul2 genes.

F- Forward primer and R- Reverse primer.

(DOCX)

pone.0299247.s001.docx (18.7KB, docx)
S2 Table. Primers: Oligonucleotide primers for the end-point PCR amplification of six pAmpCs, namely ACC, EBC, DHA, FOX, CIT and MOX gene: F- Forward primer and R- Reverse primer.

(DOCX)

pone.0299247.s002.docx (17.2KB, docx)
S3 Table. Oligonucleotide primers for the real-time PCR quantification of 16S rRNA, sul1, ermB and IntI1: F- Forward primer and R- Reverse primer.

(DOCX)

pone.0299247.s003.docx (15.5KB, docx)
S1 Appendix

(XLSX)

pone.0299247.s004.xlsx (35KB, xlsx)

Acknowledgments

The authors acknowledge Mabeo Refilwe, Abram Mahlatsi, Raimi Adekunle and Prudent Mokgokong.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

This work is based on the research supported in part by the National Research Foundation of South Africa Grant No. C2019-2020-00224 (Bursary for Karabo Tsholo), The Water Research Commission (WRC) of South Africa: (Contract - 2019/2020-00224). The views expressed are those of the authors and not of the funding agencies.

References

  • 1.Amarasiri M, Takezawa T, Malla B, Furukawa T, Sherchand JB, Haramoto E, Sei K. Prevalence of antibiotic resistance genes in drinking and environmental water sources of the Kathmandu Valley, Nepal. Frontiers in Microbiology. 2022;13:894014. doi: 10.3389/fmicb.2022.894014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yang J, Wang H, Roberts DJ, Du HN, Yu XF, Zhu NZ, et al. Persistence of antibiotic resistance genes from river water to tap water in the Yangtze River Delta. Science of the Total Environment. 2020;742:140592. doi: 10.1016/j.scitotenv.2020.140592 [DOI] [PubMed] [Google Scholar]
  • 3.Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC infectious diseases. 2014;14(1):1–25. doi: 10.1186/1471-2334-14-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Igwaran A, Iweriebor BC, Okoh AI. Molecular characterization and antimicrobial resistance pattern of Escherichia coli recovered from wastewater treatment plants in Eastern Cape South Africa. International journal of environmental research and public health. 2018;15(6):1237. doi: 10.3390/ijerph15061237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Havenga B, Ndlovu T, Clements T, Reyneke B, Waso M, Khan W. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains. BMC microbiology. 2019;19:1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.National Department of Health. Surveillance for antimicrobial resistance and consumption of antibiotics in South Africa. Pretoria. Government Printer; 2018. [Google Scholar]
  • 7.Monapathi M, Horn S, Vogt T, van Wyk D, Mienie C, Ezeokoli OT, et al. Antifungal agents, yeast abundance and diversity in surface water: potential risks to water users. Chemosphere. 2021;274:129718. doi: 10.1016/j.chemosphere.2021.129718 [DOI] [PubMed] [Google Scholar]
  • 8.Statistics South Africa. Mid-year population estimates 2021. Pretoria. Government Printer; 2022. [Google Scholar]
  • 9.Bergeron S, Raj B, Nathaniel R, Corbin A, LaFleur G. Presence of antibiotic resistance genes in raw source water of a drinking water treatment plant in a rural community of USA. International Biodeterioration & Biodegradation. 2017;124:3–9. [Google Scholar]
  • 10.Maguvu TE, Bezuidenhout CC, Kritzinger R, Tsholo K, Plaatjie M, Molale-Tom LG, et al. Combining physicochemical properties and microbiome data to evaluate the water quality of South African drinking water production plants. PLoS One. 2020;15(8):e0237335. doi: 10.1371/journal.pone.0237335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hu Y, Jin L, Zhao Y, Jiang L, Yao S, Zhou W, et al. Annual trends and health risks of antibiotics and antibiotic resistance genes in a drinking water source in East China. Science of the Total Environment. 2021;791:148152. doi: 10.1016/j.scitotenv.2021.148152 [DOI] [PubMed] [Google Scholar]
  • 12.Ateba CN, Tabi NM, Fri J, Bissong ME, Bezuidenhout CC. Occurrence of antibiotic-resistant bacteria and genes in two drinking water treatment and distribution systems in the North-West Province of South Africa. Antibiotics. 2020;9(11):745. doi: 10.3390/antibiotics9110745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Salamandane A, Alves S, Chambel L, Malfeito-Ferreira M, Brito L. Characterization of Escherichia coli from Water and Food sold on the Streets of Maputo: molecular typing, virulence genes, and Antibiotic Resistance. Applied Microbiology. 2022;2(1):133–47. [Google Scholar]
  • 14.Chen H, Zheng W, Shen X, Zhang F, Zhou X, Shen J, et al. Occurrence, distribution, and ecological risk assessment of antibiotics in different environmental media in Anqing, Anhui province, China. International Journal of Environmental Research and Public Health. 2021;18(15):8112.2. doi: 10.3390/ijerph18158112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Duong HA, Phung TV, Nguyen TN, Phan Thi LA, Pham HV. Occurrence, distribution, and ecological risk assessment of antibiotics in selected urban lakes of Hanoi, Vietnam. Journal of Analytical Methods in Chemistry. 2021;2021:1–3. doi: 10.1155/2021/6631797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ma L, Li B, Jiang XT, Wang YL, Xia Y, Li AD, et al. Catalogue of antibiotic resistome and host-tracking in drinking water deciphered by a large scale survey. Microbiome. 2017;5(1):1–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Atnafu B, Desta A, Assefa F. Microbial community structure and diversity in drinking water supply, distribution systems as well as household point of use sites in Addis Ababa City, Ethiopia. Microbial ecology. 2022;84(1):73–89. doi: 10.1007/s00248-021-01819-3 [DOI] [PubMed] [Google Scholar]
  • 18.Potgieter S, Pinto A, Sigudu M, Du Preez H, Ncube E, Venter S. Long-term spatial and temporal microbial community dynamics in a large-scale drinking water distribution system with multiple disinfectant regimes. Water Research. 2018;139:406–19. doi: 10.1016/j.watres.2018.03.077 [DOI] [PubMed] [Google Scholar]
  • 19.Vadde KK, Feng Q, Wang J, McCarthy AJ, Sekar R. Next-generation sequencing reveals fecal contamination and potentially pathogenic bacteria in a major inflow river of Taihu Lake. Environmental Pollution. 2019;254:113108. doi: 10.1016/j.envpol.2019.113108 [DOI] [PubMed] [Google Scholar]
  • 20.Department of Water and Sanitation. Blue Drop progress report. Pretoria, South Africa. Government Printer; 2022. [Google Scholar]
  • 21.Naidoo N., Pearce D., Visser Wean., Crafford J., Maila D. and Harris K. Implementation of effective wastewater charges by municipalities in South Africa: an investigation into the barriers and enablers. South Africa. Pretoria. WRC; 2016. [Google Scholar]
  • 22.South African Government News Agency. Ventersdorp water upgrade completed. 2015. [Cited 2022 Sept 02]. https://www.sanews.gov.za/south-africa/ventersdorp-water-upgrade-completed. [Google Scholar]
  • 23.Department of Water Affairs and Forestry. South African Water Quality Guidelines. Volume 1 Domestic Use 2nd edition. Pretoria. Government Printer; 1996. [Google Scholar]
  • 24.Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic acids research. 2017;45(W1):W180–8. doi: 10.1093/nar/gkx295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Coertze RD, Bezuidenhout CC. Detection and quantification of clinically relevant plasmid-mediated AmpC beta-lactamase genes in aquatic systems. Water Supply. 2020;20(5):1745–56. [Google Scholar]
  • 26.Xu Y, Xu J, Mao D, Luo Y. Effect of the selective pressure of sub-lethal level of heavy metals on the fate and distribution of ARGs in the catchment scale. Environmental Pollution. 2017;220:900–8. doi: 10.1016/j.envpol.2016.10.074 [DOI] [PubMed] [Google Scholar]
  • 27.Soran ML, Lung I, Opriş O, Floare-Avram V, Coman C. Determination of antibiotics in surface water by solid-phase extraction and high-performance liquid chromatography with diode array and mass spectrometry detection. Analytical Letters. 2017;50(7):1209–18. [Google Scholar]
  • 28.Tell J, Caldwell DJ, Häner A, Hellstern J, Hoeger B, Journel R, et al. Science-based targets for antibiotics in receiving waters from pharmaceutical manufacturing operations. Integrated environmental assessment and management. 2019;15(3):312–9. doi: 10.1002/ieam.4141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Coors A, Vollmar P, Sacher F, Polleichtner C, Hassold E, Gildemeister D, et al. Prospective environmental risk assessment of mixtures in wastewater treatment plant effluents–theoretical considerations and experimental verification. Water research. 2018;140:56–66. doi: 10.1016/j.watres.2018.04.031 [DOI] [PubMed] [Google Scholar]
  • 30.García-Ávila F, Avilés-Anazco A, Sánchez-Cordero E, Valdiviezo-Gonzáles L, Ordonez MD. The challenge of improving the efficiency of drinking water treatment systems in rural areas facing changes in the raw water quality. South African Journal of Chemical Engineering. 2021;37:141–9. [Google Scholar]
  • 31.Deyab M, El-Adl M, Ward F, Omar E. Trophic status, phytoplankton diversity, and water quality at Kafr El-Shinawy drinking-water treatment plant, Damietta. AQUA—Water Infrastructure, Ecosystems and Society. 2021;70(3):342–60. [Google Scholar]
  • 32.Amanatidou E, Samiotis G, Trikoilidou E, Pekridis G, Taousanidis N. Evaluating sedimentation problems in activated sludge treatment plants operating at complete sludge retention time. Water Research. 2015;69:20–9. doi: 10.1016/j.watres.2014.10.061 [DOI] [PubMed] [Google Scholar]
  • 33.Hussein DA, Al-Hejuje MM, Mahdi MA. Determination of water quality and pollution by micro and nano plastics in water treatment plants. Egyptian Journal of Aquatic Biology & Fisheries. 2022;26(4). [Google Scholar]
  • 34.Koekemoer L, Janse van Vuuren S, Levanets A. The influence of land use–impacted tributaries on water quality and phytoplankton in the Mooi River, North West Province, South Africa. Bothalia-African Biodiversity & Conservation. 2021;51(1):1–22. [Google Scholar]
  • 35.World Health Organization. Guidelines for drinking-water quality. 4th edition incorporating the first and second addenda. Geneva. WHO Press; 2022. [PubMed] [Google Scholar]
  • 36.United States Environmental Protection Agency. Water quality criteria. In: Water quality standards handbook. Washington, D.C. EPA; 2017. [Google Scholar]
  • 37.Holinger EP, Ross KA, Robertson CE, Stevens MJ, Harris JK, Pace NR. Molecular analysis of point-of-use municipal drinking water microbiology. Water research. 2014;49:225–35. doi: 10.1016/j.watres.2013.11.027 [DOI] [PubMed] [Google Scholar]
  • 38.Jing Z, Lu Z, Mao T, Cao W, Wang W, Ke Y, et al. Microbial composition and diversity of drinking water: A full scale spatial-temporal investigation of a city in northern China. Science of The Total Environment. 2021;776:145986. doi: 10.1016/j.scitotenv.2021.145986 [DOI] [PubMed] [Google Scholar]
  • 39.Tiwari A, Hokajärvi AM, Domingo JS, Elk M, Jayaprakash B, Ryu H, et al. Bacterial diversity and predicted enzymatic function in a multipurpose surface water system–from wastewater effluent discharges to drinking water production. Environmental microbiome. 2021;16(1):1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ryan MP, Sevjahova L, Gorman R, White S. The emergence of the genus Comamonas as important opportunistic pathogens. Pathogens. 2022;11(9):1032. doi: 10.3390/pathogens11091032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Opota O, Ney B, Zanetti G, Jaton K, Greub G, Prod’hom G. Bacteremia caused by Comamonas kerstersii in a patient with diverticulosis. Journal of clinical microbiology. 2014;52(3):1009–12. doi: 10.1128/JCM.02942-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wu Y, Zaiden N, Cao B. The core-and pan-genomic analyses of the genus Comamonas: from environmental adaptation to potential virulence. Frontiers in Microbiology. 2018;9:3096. doi: 10.3389/fmicb.2018.03096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Pritchard L, Humphris S, Saddler GS, Parkinson NM, Bertrand V, Elphinstone JG, et al. Detection of phytopathogens of the genus Dickeya using a PCR primer prediction pipeline for draft bacterial genome sequences. Plant pathology. 2013;62(3):587–96. [Google Scholar]
  • 44.Pédron J, Van Gijsegem F. Diversity in the bacterial genus Dickeya grouping plant pathogens and waterways isolates. OBM Genetics. 2019;3(4):1–22. [Google Scholar]
  • 45.Elsaghir H. and Reddivari AKR. Bacteroides fragilis. 2022. [Cited: 16 May 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553032/. [Google Scholar]
  • 46.Bautista-de Los Santos QM, Chavarria KA, Nelson KL. Understanding the impacts of intermittent supply on the drinking water microbiome. Current Opinion in Biotechnology. 2019;57:167–74. doi: 10.1016/j.copbio.2019.04.003 [DOI] [PubMed] [Google Scholar]
  • 47.Aujoulat F, Mazuet C, Criscuolo A, Popoff MR, Enault C, Diancourt L, et al. Peptoniphilus nemausensis sp. nov. A new Gram-positive anaerobic coccus isolated from human clinical samples, an emendated description of the genus Peptoniphilus and an evaluation of the taxonomic status of Peptoniphilus species with not validly published names. Systematic and Applied Microbiology. 2021;44(5):126235. [DOI] [PubMed] [Google Scholar]
  • 48.Männle D, McKinnie SM, Mantri SS, Steinke K, Lu Z, Moore BS, et al. Comparative genomics and metabolomics in the genus Nocardia. Msystems. 2020;5(3):10–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Han Z, An W, Yang M, Zhang Y. Assessing the impact of source water on tap water bacterial communities in 46 drinking water supply systems in China. Water Research. 2020;172:115469. doi: 10.1016/j.watres.2020.115469 [DOI] [PubMed] [Google Scholar]
  • 50.Mi R, Patidar R, Farenhorst A, Cai Z, Sepehri S, Khafipour E, et al. Detection of fecal bacteria and antibiotic resistance genes in drinking water collected from three First Nations communities in Manitoba, Canada. FEMS microbiology letters. 2019;366(6):fnz067. doi: 10.1093/femsle/fnz067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Golsha R, Montazeri M, Razaghi N, Zade ME. Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae. Ethiopian journal of health sciences. 2021;31(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hoseini N, Sedighi I, Mozaffari Nejad AS, Alikhani MY. Phenotypic and Genotypic Detection of AmpC Enzymes in Clinical Isolates of Escherichia coli and Klebsiella pneumoniae. Journal of Krishna Institute of Medical Sciences (JKIMSU). 2017;6(3). [Google Scholar]
  • 53.Ye Q, Wu Q, Zhang S, Zhang J, Yang G, Wang H, et al. Antibiotic-resistant extended spectrum ss-lactamase-and plasmid-mediated AmpC-producing enterobacteriaceae isolated from retail food products and the pearl river in Guangzhou, China. Frontiers in microbiology. 2017;8:96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Fadare FT, Adefisoye MA, Okoh AI. Occurrence, identification, and antibiogram signatures of selected Enterobacteriaceae from Tsomo and Tyhume rivers in the Eastern Cape Province, Republic of South Africa. PLoS One. 2020;15(12):e0238084. doi: 10.1371/journal.pone.0238084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Zhang K, Niu ZG, Lv Z, Zhang Y. Occurrence and distribution of antibiotic resistance genes in water supply reservoirs in Jingjinji area, China. Ecotoxicology. 2017;26:1284–92. doi: 10.1007/s10646-017-1853-9 [DOI] [PubMed] [Google Scholar]
  • 56.Severgnini M, Camboni T, Ceccarani C, Morselli S, Cantiani A, Zagonari S, et al. Distribution of ermB, ermF, tet (W), and tet (M) Resistance Genes in the Vaginal Ecosystem of Women during Pregnancy and Puerperium. Pathogens. 2021;10(12):1546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Alabi ME, Essack SY. Antibiotic prescribing amongst South African general practitioners in private practice: an analysis of a health insurance database. JAC-Antimicrobial Resistance. 2022;4(5):dlac101. doi: 10.1093/jacamr/dlac101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Rolbiecki D, Harnisz M, Korzeniewska E, Jałowiecki Ł, Płaza G. Occurrence of fluoroquinolones and sulfonamides resistance genes in wastewater and sludge at different stages of wastewater treatment: A preliminary case study. Applied Sciences. 2020;10(17):5816. [Google Scholar]
  • 59.Antunes P, Machado J, Sousa JC, Peixe L. Dissemination of sulfonamide resistance genes (sul1, sul2, and sul3) in Portuguese Salmonella enterica strains and relation with integrons. Antimicrobial agents and chemotherapy. 2005;49(2):836–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Africa Centres for Disease Control and Prevention. African antibiotic treatment guidelines for common bacterial infections and syndromes. African Union Commission. Addis Ababa, Ethiopia; 2022. [Google Scholar]
  • 61.Thakali O, Brooks JP, Shahin S, Sherchan SP, Haramoto E. Removal of antibiotic resistance genes at two conventional wastewater treatment plants of Louisiana, USA. Water. 2020;12(6):1729. [Google Scholar]
  • 62.Chen B, Liang X, Nie X, Huang X, Zou S, Li X. The role of class I integrons in the dissemination of sulfonamide resistance genes in the Pearl River and Pearl River Estuary, South China. Journal of Hazardous materials. 2015;282:61–7. doi: 10.1016/j.jhazmat.2014.06.010 [DOI] [PubMed] [Google Scholar]
  • 63.Mahmood AR, Al-Haideri HH, Hassan FM. Detection of antibiotics in drinking water treatment plants in Baghdad City, Iraq. Advances in Public Health. 2019;2019. [Google Scholar]
  • 64.Hu Y, Jiang L, Zhang T, Jin L, Han Q, Zhang D, et al. Occurrence and removal of sulfonamide antibiotics and antibiotic resistance genes in conventional and advanced drinking water treatment processes. Journal of hazardous materials. 2018;360:364–72. doi: 10.1016/j.jhazmat.2018.08.012 [DOI] [PubMed] [Google Scholar]
  • 65.Pulicharla R, Proulx F, Behmel S, Sérodes JB, Rodriguez MJ. Occurrence and seasonality of raw and drinking water contaminants of emerging interest in five water facilities. Science of the total environment. 2021;751:141748. doi: 10.1016/j.scitotenv.2020.141748 [DOI] [PubMed] [Google Scholar]
  • 66.Song Z, Zhang X, Ngo HH, Guo W, Wen H, Li C. Occurrence, fate and health risk assessment of 10 common antibiotics in two drinking water plants with different treatment processes. Science of the Total Environment. 2019;674:316–26. doi: 10.1016/j.scitotenv.2019.04.093 [DOI] [PubMed] [Google Scholar]
  • 67.Brauer VS, Rezende CP, Pessoni AM, De Paula RG, Rangappa KS, Nayaka SC, et al. Antifungal agents in agriculture: Friends and foes of public health. Biomolecules. 2019;9(10):521. doi: 10.3390/biom9100521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Ma Y, Li M, Wu M, Li Z, Liu X. Occurrences and regional distributions of 20 antibiotics in water bodies during groundwater recharge. Science of the Total Environment. 2015;518:498–506. doi: 10.1016/j.scitotenv.2015.02.100 [DOI] [PubMed] [Google Scholar]
  • 69.Zhou S, Di Paolo C, Wu X, Shao Y, Seiler TB, Hollert H. Optimization of screening-level risk assessment and priority selection of emerging pollutants–the case of pharmaceuticals in European surface waters. Environment International. 2019;128:1–0. doi: 10.1016/j.envint.2019.04.034 [DOI] [PubMed] [Google Scholar]
  • 70.Guan Y, Jia J, Wu L, Xue X, Zhang G, Wang Z. Analysis of bacterial community characteristics, abundance of antibiotics and antibiotic resistance genes along a pollution gradient of Ba River in Xi’an, China. Frontiers in Microbiology. 2018;9:3191. doi: 10.3389/fmicb.2018.03191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Zhang K, Fan Y, Chang S, Fu Q, Zhang Q, Yang G, et al. Characterization of antibiotic resistance genes in drinking water sources of the Douhe Reservoir, Tangshan, northern China: the correlation with bacterial communities and environmental factors. Environmental Sciences Europe. 2022;34(1):56. [Google Scholar]
  • 72.Zhou ZC, Zheng J, Wei YY, Chen T, Dahlgren RA, Shang X, et al. Antibiotic resistance genes in an urban river as impacted by bacterial community and physicochemical parameters. Environmental Science and Pollution Research. 2017;24:23753–62. doi: 10.1007/s11356-017-0032-0 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

António Machado

1 Dec 2023

PONE-D-23-28722Distribution of antibiotic resistance genes and antibiotic residues in drinking water production facilities: links to bacterial communityPLOS ONE

Dear Dr. Tsholo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

José António Baptista Machado Soares, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating in your Funding Statement: 

This work is based on the research supported in part by the National Research Foundation of South Africa Grant No. C2019-2020-00224 (Bursary for Karabo Tsholo), The Water Research Commission (WRC) of South Africa: (Contract - 2019/2020-00224). The views expressed are those of the authors and not of the funding agencies.

Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear authors,

I am pleased to inform you that both reviewers only requested minor revisions for future publication endorsement. Please carefully answer both reviewers' concerns and rectify the manuscript following their comments.

Thank you and best regards,

António Machado

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The Author has tried o identify the correlation between ARGs detected and the antibiotic residues in the drinking water facilities. However, it is not clear why only few antibiotic resistance genes were selected.

Were bacterial communities identified in the water common inhabitants of drinking water?

It looks like antibiotic residues were selected based on the ARGs identified in the water or vice versa. What is the relevance of this?

Reviewer #2: I consider authors have carried out a valid study. Experiments and analysis are appropiated for answering the research question. Since I have several comments about most of the paper sections (Abstract, Introduction, Methods, Results and Discussion), a review report have been uploaded as a PDF document.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Report-ARGs & Antibiotic Residues.pdf

pone.0299247.s005.pdf (164.8KB, pdf)
PLoS One. 2024 May 23;19(5):e0299247. doi: 10.1371/journal.pone.0299247.r002

Author response to Decision Letter 0


11 Jan 2024

Comments and Response to comments by authors for Prof José António Baptista Machado Soares

Comment: 1 Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at. Response: Where applicable the style of the manuscripts were revised to match PLOS ONE style templates

Comment: 2 In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. Response: There is a memorandum of understanding between North-West University and the local municipality responsible for the two DWPFs. However, the local municipality granted permission for this study on a condition of anonymity (lines 94 to 95).

Comment: 3 Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. Response: The Funding Statement has been amended as following: This work is based on the research supported in part by the National Research Foundation of South Africa Grant No. C2019-2020-00224 (Bursary for Karabo Tsholo), The Water Research Commission (WRC) of South Africa: (Contract – C2019-2020-00224). The views expressed are those of the authors and not of the funding agencies. The Funding Statement has been included on the cover letter.

Comment: 4: We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. Response: The grant information of the Funding Information’ and ‘Financial Disclosure’ now matches.

Comment: 5 Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Response: Captions of the Supporting Information files were included at the end of manuscript as following; S1 Table, S2 Table, S3 Table, S1 Appendix. Furthermore, in-text citations were also amended.

Comments and Response to comments by authors for reviewer 1

Comment:1 The Author has tried to identify the correlation between ARGs detected and the antibiotic residues in the drinking water facilities. However, it is not clear why only a few antibiotic resistance genes were selected. Response: The author tried to correlate bacterial communities with physicochemical parameters, ARGs and antimicrobial residues. Initially, commonly prescribed antimicrobial agents and prevalent ARGs were included in the analysis. However, due to the failed optimization for screening ARGs and quantifying antimicrobial residues, only a few parameters were included in the current study (lines 467 to 471).

Comment: 2 Were bacterial communities identified in the water common inhabitants of drinking water? Response: In this manuscript, drinking water is referred to as treated water. The bacterial composition of the drinking/treated water can be found in lines 298 to 317.

Comment: 3 It looks like antibiotic residues were selected based on the ARGs identified in the water or vice versa. What is the relevance of this? Response: The antibiotics and ARGs selected were based on their prescription and prevalence in SA respectively (lines 467 to 471).

Comments Response to comments by authors for reviewer 2

Comment: 1 Consider using “antimicrobial agents” instead when it comes to both antibiotics and fluconazole. Response: Thank you for the suggestion to use “antimicrobial agents”. However, the authors felt that the word “Antimicrobials” would fit better when referring to both antibiotics and fluconazole.

Comment: 2 In Introduction justify the importance of monitoring fluconazole or antifungals because antibiotics are not the only antimicrobials quantified in this study. Response: The justification was provided in lines 61 to 64.

Comment: 3 In Methods and materials most of the concentration units are represented as fractions (E.g.,ml/day), but concentration units of flow rate are not. Please represent all of these similarly. Response: The flow rate has been changed from mL min-1 to mL/min for consistency.

Comment: 4 The title of each section is capitalized but is not the same for the Results section. Please use the same format. Response: The format was changed from “results” to “Results”

Comment: 5 Finally, figures should have a good resolution in order to not lose text legibility. Response: Where applicable, images were replaced with higher-quality images.

Comment: 6 Line 33-34-Please replace “In NW-E, antibiotic and fluconazole concentrations…” with “Regarding antimicrobial agents, antibiotic and fluconazole concentrations. Response: Replaced as recommended

Comment: 7 Line 63-It is appropriate to only use the term “human bodies” instead of “human and human bodies” in the same sentence. Response: It was changed to “human and animal bodies”

Comment: 8 Line 79-Please use “antimicrobial agents ’residues” instead of “antibiotic residues because in the study fluconazole is also quantified. Response: It has been changed to “antimicrobial residues” rather than “antimicrobial agents’ residues” in the suggested line and others as well.

Comment: 9 Line 95-Please rectify “environmental DNA (eDNA)” Response: It was changed to as recommended “environmental DNA (eDNA)”

Comment: 10 Line 128-Verify the version of QIIME2 used in this study because the version of this software contains the year and the month. E.g., QIIME2 Version 2022.4 Response: The version of QIIME2 was changed to QIIME2 version 2022.2 (line 132)

Comment: 11 Line 142-As a suggestion change “for screening for the presence…” by “for screening the presence…” Response: Changed as recommended (line 146).

Comment: 12 Line 198-The slope symbol is “m”. Please rectify it. Response: The symbol is changed as recommended

Comment: 13 Line 225-226-It is not clarified in which cases student’s t-test and ANOVA were used when data showed a normal distribution. Response: The error was fixed. The student’s t-test was the one used when data showed a normal distribution. ANOVA was deleted.

Comment: 14 Line 274-275-Please detail the temperature results as was made with the other variables. The seasons in which temperature was measured should be specified in Table 2 and Table Response: Since this study was not based on seasonal variation, the statement was changed to “Temperature fluctuated between raw and treated water in NW-E and NW-C. In NW-E, the temperature range was between 10.3˚C and 24.1˚C. In NW-C, the range was between 13.6 ˚C and 20.9˚C. (Tables 2 and 3).” This description matches the ones of other variables.

Comment: 15 Line 299-318-“Unclassified” group should not be mentioned as phyla or genera, so for example in the first case it can be reported that there were six phyla, detailing the proportion from each of them, but a specific percentage of the sequences have not taxonomy assignation. Response: “Unclassified” was removed as part of the phyla and genera

Comment: 16 Line 491-492-Please cite the explanation of nitrite findings. Response: A citation was included [32] Amanatidou E, Samiotis G, Trikoilidou E, Pekridis G, Taousanidis N. Evaluating sedimentation problems in activated sludge treatment plants operating at complete sludge retention time. Water Research. 2015;69:20-9

Comment: 17 Line 679-686-An explanation about the risks of fluconazole presence in drinking water is recommended. Response: The explanation was provided “Its frequent application and recalcitrance to biodegradation in conventional wastewater treatment plants may lead to its prevalence in the water environment which may pose risks to water users”

Comment: 18 Most of the manuscript is well-written in a comprehensive way; nonetheless, it is recommended that redaction could be improved for avoiding redundancy. Response: Reduced were applicable.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0299247.s006.docx (49.9KB, docx)

Decision Letter 1

António Machado

8 Feb 2024

Distribution of antibiotic resistance genes and antibiotic residues in drinking water production facilities: links to bacterial community

PONE-D-23-28722R1

Dear authors,

I am pleased to inform you that both reviewers enjoyed the manuscript very much and endorsed the revised manuscript for publication.

Thank you for choosing Plos ONE journal to publish your study.

Best regards,

António Machado

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript can now be accepted for publication, since the authors have meticulously followed all the suggestion from the reviewers

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

António Machado

27 Mar 2024

PONE-D-23-28722R1

PLOS ONE

Dear Dr. Tsholo,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. António Machado

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Oligonucleotide primers for the end-point PCR amplification of ampC, blaTEM. IntI1, ermB, ermF, Sul1 and Sul2 genes.

    F- Forward primer and R- Reverse primer.

    (DOCX)

    pone.0299247.s001.docx (18.7KB, docx)
    S2 Table. Primers: Oligonucleotide primers for the end-point PCR amplification of six pAmpCs, namely ACC, EBC, DHA, FOX, CIT and MOX gene: F- Forward primer and R- Reverse primer.

    (DOCX)

    pone.0299247.s002.docx (17.2KB, docx)
    S3 Table. Oligonucleotide primers for the real-time PCR quantification of 16S rRNA, sul1, ermB and IntI1: F- Forward primer and R- Reverse primer.

    (DOCX)

    pone.0299247.s003.docx (15.5KB, docx)
    S1 Appendix

    (XLSX)

    pone.0299247.s004.xlsx (35KB, xlsx)
    Attachment

    Submitted filename: Reviewer Report-ARGs & Antibiotic Residues.pdf

    pone.0299247.s005.pdf (164.8KB, pdf)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0299247.s006.docx (49.9KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES